imidaprilat has been researched along with 1-methyl-4-phenylpyridinium in 3 studies
| Studies (imidaprilat) | Trials (imidaprilat) | Recent Studies (post-2010) (imidaprilat) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
|---|---|---|---|---|---|
| 30 | 5 | 2 | 1,854 | 1 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obata, T | 3 |
3 other study(ies) available for imidaprilat and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Protective effect of imidaprilat, a new angiotensin-converting enzyme inhibitor against 1-methyl-4-phenylpyridinium ion-induced *OH generation in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin-Converting Enzyme Inhibitors; Animals; Corpus Striatum; Dopamine Agents; Hydroxyl Radical; Imidazoles; Imidazolidines; Male; Protective Agents; Rats; Rats, Wistar | 1999 |
Imidaprilat suppresses nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin-Converting Enzyme Inhibitors; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Extracellular Fluid; Hydroxyl Radical; Imidazolidines; Male; Microdialysis; Phenols; Rats; Rats, Wistar | 2006 |
Imidaprilat, an angiotensin-converting enzyme inhibitor exerts neuroprotective effect via decreasing dopamine efflux and hydroxyl radical generation induced by bisphenol A and MPP+ in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Benzhydryl Compounds; Corpus Striatum; Dopamine; Drug Interactions; Extracellular Space; Hydroxyl Radical; Imidazolidines; Male; Neuroprotective Agents; Phenols; Rats; Rats, Wistar; Time Factors | 2006 |